1Bergenstal RM, Tamborlane WV, Ahmann A, et al. The STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in Insulin Dependent Diabetes. N Engl J Med. 2010;363(4):311-320.
2Choudhary P, Olsen BS, Conget I, Vorrink L, Shin JJ, Lee SW, Kaufman FR. Performance of the predictive low glucose management feature of the MiniMed 640G system in a user evaluation study [abstract]. Diabetes. 2015; 64 (suppl 1):A277
3Bergenstal, R.M. N Engl J Med. 2013, 10.1056.
4Fidler C, Elmelund CT, Gillard S. Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econ 2011;14:646–55
5Brod, M. JME. 2012, 15 (5) 869–877.
6The ISO 15197:2013 standard stipulates that 95% of the measured glucose values need to fall within either ±0.83 mmol/L of the average measured values of the reference measurement procedure at glucose concentrations <5.55 mmol/L or within ±15% at glucose concentrations ≥5.55 mmol/L.
799% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid for type 1 diabetes2.
*When using the CONTOUR™NEXT LINK 2.4 Blood Glucose Meter by Ascensia Diabetes Care
**Waterproof at time of manufacture up to 3.6 meters for up to 24 hours at a time. See MiniMed 640G User Guide for a complete description of the waterproof capabilities and proper use instructions.
See MiniMed 640G User Guide for a complete description of the waterproof capabilities and proper use instructions.